Dephosphorylation of Y685-VE-Cadherin Involved in Pulmonary Microvascular Endothelial Barrier Injury Induced by Angiotensin II

Table 1

Clinical features of the patients.

	Control	Nonruptured aneurysm	AAD
			Complicated with lung injury AAD	Nonlung injury AAD
Age, yr	40 ± 9	58 ± 11	47 ± 6	51 ± 6
Male sex, %	8 (66.7)	8 (66.7)	17 (81.0)	30 (81.1)
Average duration from onset, h	N/A	N/A	9.2	10.7
Smoking, (%)	4 (33.3)	5 (41.7)	11 (52.4)	19 (51.4)